Don't think a link to this publication has been posted:
https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12367
This is a Spanish study in which the authors proplose that the upregulartion of ApoA-1 by apabetalone is reponsible for reduced malignancy in colorectal cancer cells.